True, most likely, but it could possibly save many lives in the future. Also, there are many antivirals that are known to potentially be effective which just h

True, most likely, but it could possibly save many lives in the future. Also, there are many antivirals that are known to potentially be effective which just haven't gone through all of the rigorous years of testing to be market-ready. A startup could possibly try to more rapidly evaluate the ones that made it the furthest, so they could potentially be used for critically ill patients who so far have not responded to treatment. That could be a short-term benefit, and that same research could also get the drugs to market faster in the long-term as well.